# References

1. Trounson A, McDonald C (2015) Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17:11–22. https://doi.org/10.1016/j.stem.2015.06.007
2. Xing J, Ying Y, Mao C et al (2018) Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota. Nat Commun 9:2020. https://doi.org/10.1038/s41467-018-04453-9
3. Panes J, García-Olmo D, Van Assche G, Colombel J (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388:1281–1290
4. Dhere T, Copland I, Garcia M, Chiang K (2016) The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn’s disease—a phase 1 trial with three doses. Aliment Pharmacol Ther 44:471–481
5. Jiang W, Tan Y, Cai M et al (2018) Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect. Stem Cells Int 2018:1–11. https://doi.org/10.1155/2018/6079642
6. Martín Arranz E, Martín Arranz MD, Robredo T, Mancheño-Corvo P (2018) Endoscopic submucosal injection of adipose-derived mesenchymal stem cells ameliorates TNBS-induced colitis in rats and prevents stenosis. Stem Cell Res Ther 9:95. https://doi.org/10.1186/s13287-018-0837-x
7. Song J, Kang HJ, Hong JS et al (2017) Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep 7:9412. https://doi.org/10.1038/s41598-017-09827-5
8. Hu J, Zhao G, Zhang L et al (2016) Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med 12:2983–2989. https://doi.org/10.3892/etm.2016.3724
9. Zhang J, Lv S, Liu X et al (2018) Umbilical cord mesenchymal stem cell treatment for Crohn’s disease: a randomized controlled clinical trial. Gut Liver 12:73–78. https://doi.org/10.5009/gnl17035
10. Forbes GM, Sturm MJ, Leong RW et al (2014) A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy. Clin Gastroenterol Hepatol 12:64–71. https://doi.org/10.1016/j.cgh.2013.06.021
11. Lazebnik LB, Kniazev OV, Konopliannikov AG et al (2010) Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation. Eksp Klin Gastroenterol 11:3–15
12. Lazebnik LB, Kniazev OV, Parfenov AI et al (2010) Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse. Eksp Klin Gastroenterol 3:5–10
13. Sanz-Baro R, García-Arranz M, Guadalajara H et al (2015) First-in-human case study: pregnancy in women with Crohn’s perianal fistula treated with adipose-derived stem cells: a safety study. Stem Cells Transl Med 4:598–602. https://doi.org/10.5966/sctm.2014-0255
14. Shi X, Chen Q, Wang F (2019) Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies. Stem Cell Res Ther 10:266. https://doi.org/10.1186/s13287-019-1336-4
15. Robinson AM, Rahman AA, Miller S et al (2017) The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Res Ther 8:87. https://doi.org/10.1186/s13287-017-0540-3
16. Lee B-C, Shin N, Lee JY et al (2018) MIS416 enhances therapeutic functions of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis by modulating systemic immune milieu. Front Immunol. https://doi.org/10.3389/fimmu.2018.01078
17. Yang FY, Chen R, Zhang X et al (2018) Preconditioning enhances the therapeutic effects of mesenchymal stem cells on colitis through PGE2-mediated T-cell modulation. Cell Transplant 27:1352–1367. https://doi.org/10.1177/0963689718780304
18. Ciccocioppo R, Cangemi GC, Kruzliak P et al (2015) Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. Stem Cell Res Ther 6:137. https://doi.org/10.1186/s13287-015-0122-1
19. Cho Y, Park K, Yoon S, Song K (2015) Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula. Stem Cells Transl Med 4:532–537
20. Guadalajara H, Herreros D, De-La-Quintana P, Trebol J (2012) Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27:595–600. https://doi.org/10.1007/s00384-011-1350-1
21. Kamada N, Nunez G (2014) Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 146:1477–1488
22. Xiao E, He L, Wu Q et al (2017) Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation. Stem Cell Res Ther 8:213. https://doi.org/10.1186/s13287-017-0670-7
23. Soontararak S, Chow L, Johnson V et al (2018) Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model. Stem Cells Transl Med 7:456–467. https://doi.org/10.1002/sctm.17-0305
24. Nagashima K, Sawa S, Nitta T et al (2017) Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat Immunol 18:675–682. https://doi.org/10.1038/ni.3732
25. Kol A, Foutouhi S, Walker NJ et al (2014) Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions. Stem Cells Dev 23:1831–1843. https://doi.org/10.1089/scd.2014.0128
26. Iwamura C, Bouladoux N, Belkaid Y et al (2017) Sensing of the microbiota by NOD1 in mesenchymal stromal cells regulates murine hematopoiesis. Blood 129:171–176. https://doi.org/10.1182/blood-2016-06-723742
27. Uccelli A, Laroni A, Freedman MS (2011) Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 10:649–656. https://doi.org/10.1016/S1474-4422(11)70121-1
28. Watanabe S, Arimura Y, Nagaishi K et al (2014) Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors. J Gastroenterol 49:270–282. https://doi.org/10.1007/s00535-013-0901-3
29. Nicholson JK, Holmes E, Kinross J et al (2012) Host–gut microbiota metabolic interactions. Science 336:1262–1267. https://doi.org/10.1126/science.1223813
30. Dong X, Feng X, Liu J et al (2019) Characteristics of intestinal microecology during mesenchymal stem cell-based therapy for mouse acute liver injury. Stem Cells Int 2019:1–14. https://doi.org/10.1155/2019/2403793
31. Riehl TE, Alvarado D, Ee X et al (2019) Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells. Gut 68:1003–1013. https://doi.org/10.1136/gutjnl-2018-316226
32. Ferrand J, Lehours P, Schmid-Alliana A et al (2011) Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-κB-dependent pathway. PLoS ONE 6:e29007. https://doi.org/10.1371/journal.pone.0029007
33. Buffie C, Pamer E (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–801
34. Huang T, Zhang X, Pan J et al (2016) Purification and characterization of a novel cold shock protein-like bacteriocin synthesized by Bacillus thuringiensis. Sci Rep 6:35560
35. Kinnebrew M, Ubeda C, Zenewicz LA et al (2010) Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 201:534–543
36. Ivanov I, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498
37. Kamada N et al (2012) Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science (80−) 336:1325–1329
38. Ferreira RB et al (2011) The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS ONE 6:e20338
39. Kamada N, Seo S-U, Chen GY, Núñez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13:321–335. https://doi.org/10.1038/nri3430
40. Krasnodembskaya A, Samarani G, Song Y et al (2012) Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative